Study 1 of 6Tesofensine literatureSemanticScholar2010
Semantic Scholar search for Tesofensine
Not reported in abstract.
Where it sits
this study against the rest of the tesofensine corpus1
Preclinical · this one
3
Observational
1
Open-label
1
Randomised
0
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2010
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.
- Not reported in abstract.
Elsewhere in the Tesofensine corpus
BSystematic review of influence of ethnicity on efficacy and safety of pharmacotherapy for childhood and adolescent obesity.Clinical and experimental pediatrics · 2026 · Not reported in abstract.HumanAAscending single-dose study of the safety, pharmacokinetics, and pharmacodynamics of CSTI-500, a novel monoamine triple reuptake inhibitor, first-in-human.Psychopharmacology · 2026 · Mean striatal SERT occupancy was 72% at 4-6 h post-dose, n=6.HumanBFactors associated with acquired hypothalamic obesity in children with hypothalamic tumors: a comparative single-center study.Endocrine · 2026 · Obesity developed in 15 patients (44.1%) out of 34 pediatric patients with hypothalamic tumors.HumanBInvestigations Into the Metabolism and Elimination of Tesofensine in Human Urine.Drug testing and analysis · 2026 · Peak concentrations of 1-4 ng/mL after 4-46 h, n=6.HumanBInvestigations Into the Metabolism and Elimination of Tesofensine in Human Urine.PubMed · 2026 · Peak concentrations of 1-4 ng/mL after 4-46 h, n=6.Human